Found 6 matching trials
A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP
PHASE2This international, multi-centre, double-blind vaccine study is a three-arm...
Location
MRC/UVRI and LSHTM Uganda Research Unit
Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy
PHASE1The purpose of this study is to determine the safety of two recombinant HIV...
Location
Children's Hospital Los Angeles NICHD CRS
An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients
PHASE2The objective of the study is to compare two doses of MVA-nef vs. MVA-BN to...
Location
University of Erlangen
Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults
PHASE1The purpose of this study is to determine the safety of an immune response ...
Location
Rockefeller University Hospital
Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults
PHASE1The purpose of this study is to evaluate the safety of and immune response ...
Location
Alabama Vaccine CRS
Investigating Immunisation Strategies of DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody Responses
PHASE1UKHVC Spoke 003 is a randomised Phase I, two centre study which will explor...
Location
Surrey Clinical Research Centre, University of Surrey